Drug · DIN 02498472
DAURISMO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since August 10, 2020; first marketed August 10, 2020.
- Drug Identification Number (DIN)
- 02498472
- Company (DIN owner)
- Pfizer Canada UlcKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Glasdegib L01XJ03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GLASDEGIB (GLASDEGIB MALEATE) | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 28, 2020: NOC 23517New Drug Submission (NDS)
Other DINs named DAURISMO
- DIN 02498480 · Marketed